These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11406256)

  • 1. FK 506 dose in transplantation: from theory to practice.
    Faivre L; Saoudi S; Astier A; Hamadas C; Conort O; Boivin H; Sabatier B; Taburet A; Lecointre K; Bellanger A; Radideau E; Thuillier A
    Transplant Proc; 2001 Jun; 33(4):2594-7. PubMed ID: 11406256
    [No Abstract]   [Full Text] [Related]  

  • 2. Tacrolimus in solid organ transplantation: an update.
    Shapiro R
    Transplant Proc; 1999 Sep; 31(6):2203-5. PubMed ID: 10500545
    [No Abstract]   [Full Text] [Related]  

  • 3. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 4. FK 506 in simultaneous pancreas/kidney transplantation: the University of Miami experience.
    Demirbas A; Ciancio G; Burke G; Roth D; Karatzas T; Tzakis A; Miller J
    Transplant Proc; 1997 Nov; 29(7):2903. PubMed ID: 9365608
    [No Abstract]   [Full Text] [Related]  

  • 5. FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group.
    Miller J; Pirsch JD; Deierhoi M; Vincenti F; Filo RS
    Transplant Proc; 1997; 29(1-2):304-5. PubMed ID: 9123008
    [No Abstract]   [Full Text] [Related]  

  • 6. Two-year experience with FK 506 in pediatric patients.
    Tzakis AG; Reyes J; Todo S; Nour B; Shapiro R; Jordan M; McCauley J; Armitage J; Fung JJ; Starzl TE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):619-21. PubMed ID: 7679822
    [No Abstract]   [Full Text] [Related]  

  • 7. Tacrolimus (FK 506)-induced hemolytic uremic syndrome after heart transplantation.
    Walder B; Ricou B; Suter PM
    J Heart Lung Transplant; 1998 Oct; 17(10):1004-6. PubMed ID: 9811409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of tacrolimus in primary kidney transplant patients: multicenter, open-label prospective study.
    Park K; Ahn C; Bang BK; Kang CM; Kim SI; Kim SJ; Kim YS; Kim YS; Koh YB; Kwak JY; Kwon OJ; Moon IS; Moon JI;
    Transplant Proc; 2000 Nov; 32(7):1705-8. PubMed ID: 11119901
    [No Abstract]   [Full Text] [Related]  

  • 9. Conversion to neoral provides effective rescue therapy for liver and kidney transplant patients intolerant of Prograf.
    Abouljoud M; Kumar MS; Brayman K; Emre S; Bynon SJ
    Transplant Proc; 2001; 33(1-2):1027-8. PubMed ID: 11267175
    [No Abstract]   [Full Text] [Related]  

  • 10. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
    Bechstein WO; Neuhaus P; McMaster P; Calne R; Pichlmayr R; Otto G; Williams R; Ericzon BG; Bismuth H
    Transplant Proc; 1996 Apr; 28(2):1008-10. PubMed ID: 8623211
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group.
    Wiesner RH
    Transplant Proc; 1998 Jun; 30(4):1399-400. PubMed ID: 9636565
    [No Abstract]   [Full Text] [Related]  

  • 12. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience.
    Rossi G; Reggiani P; Orsenigo R; Leoni L; Caccamo L; Doglia M; Gatti S; Maggi U; Paone G; Galmarini D; Fassati LR
    Transplant Proc; 1998 Jun; 30(4):1391-3. PubMed ID: 9636562
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients.
    Kliem V; Schaumann D; Ehlerding G; Eberhard OK; Lufft V; Schlitt HJ; Pichlmayr R; Koch KM; Brunkhorst R
    Transplant Proc; 1997 Nov; 29(7):2955-7. PubMed ID: 9365627
    [No Abstract]   [Full Text] [Related]  

  • 15. Tacrolimus (FK 506) in kidney transplantation.
    Vanrenterghem Y
    Transplant Proc; 1998 Aug; 30(5):2171-3. PubMed ID: 9723431
    [No Abstract]   [Full Text] [Related]  

  • 16. Tacrolimus (FK-506) in kidney transplantation.
    Shapiro R
    Transplant Proc; 1997; 29(1-2):45-7. PubMed ID: 9123077
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
    Yu L; Wang Y; Fu SJ; Cheng XJ
    Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902
    [No Abstract]   [Full Text] [Related]  

  • 18. Tacrolimus: immunosuppression following liver and kidney transplant.
    Clark W
    J Clin Pharm Ther; 1996 Jun; 21(3):135-41. PubMed ID: 8873845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus (FK506) as primary immunosuppressant after lung transplantation.
    Kur F; Reichenspurner H; Meiser BM; Welz A; Fürst H; Müller C; Vogelmeier C; Schwaiblmaier M; Briegel J; Reichart B
    Thorac Cardiovasc Surg; 1999 Jun; 47(3):174-8. PubMed ID: 10443520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up?
    Groetzner J; Meiser BM; Schirmer J; Koglin J; vScheidt W; Klauss V; Cremer P; Reichenspurner H; Reichart B
    Transplant Proc; 2001; 33(1-2):1461-4. PubMed ID: 11267373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.